AwardTape · Defense awards · Research and development · Health R&D · DAMD1798C8024
DAMD1798C8024: -$102.6M definitive contract to Dynport Vaccine Company LLC
Dynport Vaccine Company LLC holds a definitive contract from Defense Contract Management Agency with -$102.6M obligated since Oct 2023 and $806.3M obligated over its life, against a ceiling of $1.2B. Latest action Feb 5, 2024.
| PIID | DAMD1798C8024 |
|---|---|
| Type | definitive contract |
| Company | Dynport Vaccine Company LLC |
| Agency | Defense Contract Management Agency |
| Contracting office | DCMA MID-ATLANTIC (BALTIMORE) |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Obligated since Oct 2023 | -$102.6M |
| Total obligated (lifetime) | $806.3M |
| Ceiling (base and all options) | $1.2B |
| Base date | Nov 6, 1997 |
| Latest action | Feb 5, 2024 |
| End date | Jul 23, 2023 |
| Actions since Oct 2023 | 1 |
| Pricing | Cost plus award fee |
| Competition | Full and open competition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial